In the wake of this ruling, many worldwide agencies established health care divisions to carve out their share of the market. Already, Leo Burnett USA has established an impressive track record in health care marketing, directing the high-profile launch of Celebrex, spearheading the first Prozac advertising in 1997 as well as guiding the Allegra account in 1998. The company also released a LeoHealth study at its launch, an in-house report that segments the various consumers of the health care industry. Ambush Interview sat down with LeoHealth chief executive officer Toby Sachs to discuss LeoHealth, the company's philosophy about the health care buyer as well as future network possibilities for medical health care advertising agencies. Leo Burnett USA has been mounting ad campaigns for various pharmaceutical companies for a few years now.
Most people get an idea, and run out and sell it.
We've been advertising for health brands for 65 years now. Not was the time to get out there and tell people about our successes. We're split on this answer. We very much want to stay under the Leo Burnett name. People come to us because they respect what Leo has done in building consumer brands and are excited to know that we have experience in the health care field.